Achieve life sciences to participate in upcoming investor conferences

Seattle, wa and vancouver, bc / accesswire / september 15, 2021 / achieve life sciences, inc. (nasdaq:achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that john bencich, chief executive officer, will participate in two upcoming investor conferences. mr. bencich will present at the virtual oppenheimer fall healthcare life sciences & medtech summit on tuesday, september 21st at 3:45pm et.
ACHV Ratings Summary
ACHV Quant Ranking